Pfizer to Seek to Appeal Lipitor Enantiomer Patent Ruling in the Netherlands, Company Notes That Ruling Has No Commercial Impact
NEW YORK–(BUSINESS WIRE)–Feb 28, 2008 - Pfizer Inc said today
that it will seek to appeal a ruling of the Court of Appeal of The
Hague in the Netherlands that Pfizer’s atorvastatin enantiomer
patent is invalid. The patent (EP 409,281) had been…
King Pharmaceuticals Reports Year-End and Fourth-Quarter 2007 Financial Results
BRISTOL, Tenn.–(BUSINESS WIRE)–Feb 28, 2008 - King
Pharmaceuticals, Inc. (NYSE:KG) announced today that total revenues
increased 7% to a record high $2.14 billion during the year ended
December 31, 2007, compared to $1.99 billion for 2006….
Support for the Physician Payments Sunshine Act, S.2029
WASHINGTON, Feb. 27,
2008-Senator Chuck Grassley, Ranking Member of the Committee on
Finance, today commented on statements made yesterday by Medtronic,
Inc. and AdvaMed in support of disclosing payments made by
pharmaceutical drug, medical device…
Novartis and Sony Pictures Television International’s Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America
MIAMI, February 27, 2008 /PRNewswire/ — Novartis and Sony
Pictures Television International’s (SPTI) Latin American
advertising sales group today launched “SER,” a breast cancer
prevention and early detection campaign in support of Latin
American…
Merck Retains Interest in AstraZeneca LP Products
WHITEHOUSE STATION, N.J.–(BUSINESS WIRE)–Feb 28, 2008 - Merck
& Co., Inc. announced today that it has advised AstraZeneca PLC
that it will not exercise its option to sell its interest in
certain AstraZeneca non-proton pump inhibitor (non-PPI)…
Wenning: 2007 Was Bayer’s Most Successful Year to Date
Sales grew 11.8 percent to EUR 32,385 million / EBITDA before
special items advanced 21.4 percent to EUR 6,777 million /
Performance target for 2007 exceeded: underlying EBITDA margin of
20.9 percent / EBIT before special items climbed 23.2 percent…
AstraZeneca Provides An Update on the Status of its Arrangements With Merck & Co., Inc.
LONDON, Feb. 28, 2008-AstraZeneca today announced that, under
the provisions of the agreements relating to the restructuring of
the AstraZeneca and Merck & Co. joint venture in the United
States, AstraZeneca has been informed that Merck has…
‘U’ study finds drug effective against ovarian cancer
“We found that patients who received topotecan plus thalidomide showed an overall response rate of 47 percent compared to 21 percent response in patients who received only topotecan”
Thalidomide, a drug blamed in the 1950s for causing birth defects, is now showing promise as a safe and effective treatment for women with recurrent ovarian cancer, according to a study led the University of … via KSTP-TV Minneapolis
Colo. church shooter had ADHD and felt rejected but didn’t discuss violence, parents say
“He was told he was loved every day”
A young man who killed four people at a church and a missionary training center had attention deficit hyperactivity disorder and harbored bitterness for being an outcast, his parents said in their first … via WSVN-TV Miami Beach
Anemia drugs raise cancer-death risk
“What he observes is the risks that we’ve already talked about that are in the label”
Widely used anemia drugs sold by Amgen and Johnson & Johnson raise the risk of death among cancer patients by about 10 percent, according to a new analysis of previous clinical trials that is to be published … via HeraldTribune.com
« go back — keep looking »